not selective. 1 and 2 had good activity against MCF7, some with lower IC50 than 5-FU. Complexes with X = Br or I had moderate activity against Caco-2 and HepG2, but those with Cl were inactive. Antibacterial activities of 1a, 2b, 3a, and 7 were tested against antibacterial susceptible and resistant Gram-negative and -positive bacteria. 1a, 2b, and 3a showed activity against methicillin-resistant S
新配合物 [(η6-p-cymene)Ru(
C5H4N-2-CH=N-Ar)X]PF6 [X = Br (1), I (2); Ar = 4-
氟苯基 (a)、4-
氯苯基 (b)、4-
溴苯基 (c)、4-
碘苯基 (d)、2,5-二
氯苯基 (e)] 以及 3a–3e (X = Cl) 和新的配合物 [(η6-arene)RuCl(NN)]PF6 (arene = C6H5OCH2CH2OH, NN = 2,2'-bipyridine (4), 2,6-(二甲基苯基)-pyridin-2-yl-亚甲基胺 (5), 2,6-(
二异丙基苯基)-
吡啶-2-基-亚甲基胺 (6);
芳烃 =
对伞花烃, NN = 4-(
氨基苯基)-
吡啶-2-基-亚甲基胺 (7 )]. 对 1a、1b、1c、1d、2b、5 和 7 进行了 X 射线衍射研究。确定了 1a-1d 和 2 与人类癌细胞上皮结直肠腺癌 (Caco-2)